Back to Search Start Over

Lyotropic liquid crystal mesophases as transdermal delivery systems for lipophilic drugs: A comparative study.

Authors :
de Araujo GRS
Azevedo Lima OV
Barreto Neujahr JP
Matos SS
de Souza TA
Dos Santos AM
Chorilli M
de Souza Araujo AA
Duarte MC
da Cunha Gonsalves JKM
de Souza Nunes R
Dos Santos MRV
Vitorino Sarmento VH
Moreira Lira AA
Source :
International journal of pharmaceutics [Int J Pharm] 2023 Apr 05; Vol. 636, pp. 122853. Date of Electronic Publication: 2023 Mar 15.
Publication Year :
2023

Abstract

The present work aimed to evaluate different Liquid Crystal Mesophases (LCM) as transdermal drug delivery systems (TDDS) for nifedipine (NFD), a lipophilic drug model. The formulations composed of water, Citrus sinensis essential oil (CSEO), PPG-5-CETETH-20, and Olive oil ester PEG-7 were obtained and characterized by polarized light microscopy (PLM), rheology, small-angle x-ray scattering (SAXS), Fourier transform infrared coupled with an attenuated total reflection accessory (FTIR-ATR) and in vitro assays: bioadhesion, drug release, skin permeation, and retention tests. As a result, changes in component proportions led to several transparent viscous systems with an anisotropic profile. PLM and SAXS proved the presence of lamellar (S1), hexagonal (S3), and lamellar + hexagonal (S2) LCM, and rheology showed a high viscoelasticity profile. LCMs were able to adhere to the skin, and S2 achieved higher adhesion strength. NFD (5 mg/mL) has not modified the organization of LCMs. Results also showed that S3 promoted higher permeation and retention and higher disorganization of stratum corneum lipids, which is the main permeation-enhancing mechanism. Thus, the formulations obtained can carry and improve drug delivery through the skin and are promising TDDS for lipophilic drug administration, such as NFD.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2023 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1873-3476
Volume :
636
Database :
MEDLINE
Journal :
International journal of pharmaceutics
Publication Type :
Academic Journal
Accession number :
36931537
Full Text :
https://doi.org/10.1016/j.ijpharm.2023.122853